Algert Global LLC Day One Biopharmaceuticals, Inc. Transaction History
Algert Global LLC
- $4.77 Billion
- Q2 2025
A detailed history of Algert Global LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Algert Global LLC holds 906,042 shares of DAWN stock, worth $6.71 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
906,042
Previous 371,380
143.97%
Holding current value
$6.71 Million
Previous $2.95 Million
99.97%
% of portfolio
0.12%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
69.2MCall Options Held
122KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$47.6 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$45.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$33.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$30.4 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$27.6 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $544M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...